RM, A., T, M., ML, L., T, W., EB, M., KM, B., & MD, S. (2026). Urinary orosomucoid and the risk of cardiovascular events and all-cause mortality in the general population. The Tromsø Study 2007-2021. Atherosclerosis, 417, 120776. https://doi.org/10.1016/j.atherosclerosis.2026.120776
Chicago Style (17th ed.) CitationRM, Andreassen, Melsom T, Løchen ML, Wilsgaard T, Mathiesen EB, Brobak KM, and Solbu MD. "Urinary Orosomucoid and the Risk of Cardiovascular Events and All-cause Mortality in the General Population. The Tromsø Study 2007-2021." Atherosclerosis 417 (2026): 120776. https://doi.org/10.1016/j.atherosclerosis.2026.120776.
MLA (9th ed.) CitationRM, Andreassen, et al. "Urinary Orosomucoid and the Risk of Cardiovascular Events and All-cause Mortality in the General Population. The Tromsø Study 2007-2021." Atherosclerosis, vol. 417, 2026, p. 120776, https://doi.org/10.1016/j.atherosclerosis.2026.120776.